The production of novel, motivated or useful material defines creativity, which appears to be one of the higher, specific, human brain functions. While creativity can express itself in virtually any domain, art might particularly well illustrate how creativity may be modulated by the normal or pathological brain. Evidence emphasizes global brain functioning in artistic creativity and output, but critical steps which link perception processing to execution of a work, such as extraction-abstraction, as well as major developments of non-esthetic values attached to art also underline complex activation and inhibition processes mainly localized in the frontal lobe. Neurological diseases in artists provide a unique opportunity to study brain-creativity relationships, in particular through the stylistic changes which may develop after brain lesion.

Keywords:
Artistic creativity, Brain disorders, Stroke
1.
Grohmann W: Paul Klee. Paris, Flinker, 1954.
2.
Sternberg RJ, Kaufmann JC, Pretz JE: The Creativity Conundrum. A Propulsion Model of Kinds of Creative Contributions. Essays in Cognitive Psychology. New York, Psychology Press, 2002.
3.
Barron F, Harrington DM: Creativity, intelligence, and personality. Ann Rev Psychol 1981;32:439–476.
4.
Andreason NC: Creativity and mental illness: prevalence rates in writers and their first-degree relatives. Am J Psychiatry 1987;144:1288–1292.
5.
Jamison KR: Mood disorders and pattern of creativity in British writers and artists. Psychiatry 1989;52:125–134.
6.
Schildkraut JJ, Otero A (eds): Depression and the Spiritual in Modern Art. Chichester, Wiley, 1996.
7.
Stickgold R, Walker M: To sleep, perchance to gain creative insight? Trends Cogn Sci 2004;8:191–192.
8.
Bogousslavsky J: Le rêve est-il une seconde vie? Méd Hyg 2002;2390:875–876.
9.
Zeki S: Inner Vision. An Exploration of Art and the Brain. Oxford, Oxford University Press, 1999.
10.
Kalbfleisch ML: Functional neural anatomy of talent. Anat Rec B New Anat 2004;277:21–36.
11.
Rose FC (ed): Neurology of the Arts. Painting, Music Literature. London, Imperial College Press, 2004.
12.
Bogousslavsky J, Boller F (eds): Neurological Disorders in Famous Artists. Front Neurol Neurosci. Basel, Karger, 2005, vol 19.
13.
Fitzgerald M: Autism and Creativity: Is There a Link between Autism in Men and Exceptional Ability? Brunner-Routledge, 2003.
14.
Snyder AW, Mulcahy E, Taylor JL, Mitchell DJ, Sachder P, Gandevia SC: Savant-like skills exposed in normal people by suppressing the left fronto-temporal lobe. J Integr Neurosci 2003;2:149–158.
15.
Poole R: ‘Kind of blue’: creativity, mental disorder and jazz. Br J Psychiatry 2003;183:193–194.
16.
Tanabe H, Nakagawa Y, Ikeda M, Hashimoto M, Yamota N, Kazui H, Nishikawa T, Okuda J: Selective loss of semantic memory for words; in Ishikawa K, Mc Gaugh JL, Sakata H (eds): Brain Processes of Memory. Amsterdam, Elsevier Science BV, 1996, pp 141–152.
17.
Miller BL, Ponton M, Benson DF, Cummings JL, Mena I: Enhanced artistic creativity with temporal lobe degeneration. Lancet 1996;348:1744–1745.
18.
Miller BL, Cummings JL, Boone K: Emergence of artistic talent in fronto-temporal dementia. Neurology 1998;51:978–981.
19.
Miller BL, Boone K, Cummings JL, Read Sl, Mishkin F: Functional correlates of musical and visual ability in fronto-temporal dementia. Br J Psychiatry 2000;176:458–463.
20.
Ihang Mell J, Howard SM, Miller BL: Art and the brain. The influence of fronto-temporal dementia on an accomplished artist. Neurology 2003;60:1707–1710.
21.
Schrag A, Trumble M: Poetic talent unmasked by treatment of Parkinson’s disease. Mov Disord 2001;16:1175–1176.
22.
Bogousslavsky J: L’amour perdu de Gui et Madeleine. Le syndrome émotionnel et comportemental temporal de Guillaume Apollinaire. Rev Neurol (Paris) 2003;15:171–179.
23.
Bogousslavsky J: Guillaume Apollinaire, the lover assassinated; in Bogousslavsky J, Boller F (eds): Neurological Disorders in Famous Artists. Front Neurol Neurosci. Basel, Karger, 2005, vol 19, pp 1–8.
24.
Witelson SF, Kigar DL, Harvey T: The exceptional brain of Albert Einstein. Lancet 1999;353:2149–2153.
25.
Bentivoglio M: Cortical structure and mental skills: Oscar Vogt and the legacy of Lenin’s brain. Brain Res Bull 1998;47:219–296.
26.
Hennerici MG, Bäzner H: Personal communication, 2005.
27.
Cantagallo A, Della Sala S: Preserved insight in an artist with extrapersonal spatial neglect. Cortex 1998;34:163–183.
28.
Annoni JM, Devuyst G, Carota A, Bruggimann L, Bogousslavsky J: Changes in artistic style after minor posterior stroke. J Neurol Neurosurg Psychiatry 2005;76:797–803.
29.
Blanke O, Landis T: The metaphysical art of Giorgio de Chirico. Migraine or epilepsy? Eur Neurol 2003;50:191–194.
30.
Bogousslavsky J: The neurology of art. The example of Giorgio de Chirico. Eur Neurol 203; 50:189–190.
31.
Mendez MF: Dementia as a window to the neurology of art. Med Hypotheses 2004;63:1–7.
32.
Espinel CH: de Kooning’s late colours and forms: Dementia, creativity, and the healing power of art. Lancet 1996;347:1096–1098.
33.
Alajouanine T: Aphasia and artistic realization. Brain 1948;71:229–241.
34.
Bogousslavsky J: Le cerveau et l’art, aux frontières de la neurologie. Méd Hyg 2000;2300:1027–1029.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.